Ostrum Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.1M Buy
74,093
+6,090
+9% +$6.17M 3.83% 5
2025
Q4
$73.1M Sell
68,003
-1,636
-2% -$1.56M 3.51% 6
2025
Q3
$53.1M Buy
69,639
+55,579
+395% +$41.4M 2.39% 8
2025
Q2
$11M Buy
14,060
+1,289
+10% +$1M 0.51% 30
2025
Q1
$10.5M Buy
12,771
+520
+4% +$433K 0.56% 27
2024
Q4
$9.46M Buy
12,251
+2,514
+26% +$2.08M 0.82% 12
2024
Q3
$8.63M Buy
9,737
+1,375
+16% +$1.24M 0.71% 16
2024
Q2
$7.57M Sell
8,362
-3,169
-27% -$2.53M 0.66% 18
2024
Q1
$8.97M Sell
11,531
-493
-4% -$351K 0.71% 14
2023
Q4
$7.01M Sell
12,024
-601
-5% -$351K 0.61% 21
2023
Q3
$6.78M Sell
12,625
-2,530
-17% -$1.3M 0.63% 17
2023
Q2
$7.11M Buy
15,155
+388
+3% +$163K 0.6% 21
2023
Q1
$5.07M Buy
+14,767
New +$4.98M 0.44% 52

Other funds holding LLY

Ostrum Asset Management's LLY Position: Q1 2026 in Review

Ostrum Asset Management increased its Eli Lilly (LLY) stake by 9% in Q1 2026, buying an estimated $6.17M and bringing the position to 74,093 shares worth $68.1M. The position accounts for 3.83% of the portfolio, ranked #5.

Ostrum Asset Management first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $73.1M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ostrum Asset Management held 74,093 shares of Eli Lilly worth $68.1M as of Q1 2026.
  • Ostrum Asset Management bought 6,090 Eli Lilly shares in Q1 2026, an estimated $6.17M.
  • Eli Lilly made up 3.83% of Ostrum Asset Management's portfolio in Q1 2026, its #5 holding.
  • Ostrum Asset Management first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
  • Ostrum Asset Management's Eli Lilly position peaked at $73.1M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.